As pharmaceutical companies wage a legislative battle, you, the consumer could end up with even higher drug prices.

A patent law change sought by the pharmaceutical industry could cost federal health-care programs $1.3 billion over a decade by delaying new generic medicines, an analysis by the Congressional Budget Office found this summer, according to people familiar with the matter.

Read article

Search Website